在COVID-19中康复的患者中多器官水平功能障碍的动态评估:DYNAMO COVID-19
Ayushman Gupta1,2,3, Rosemary Nicholas4, Jordan J McGing5
1NIHR Nottingham Biomedical Research Centre, Nottingham, UK.
Experimental physiology
|June 26, 2024
概括
严重的COVID-19幸存者在康复几个月后表现出增加的胰岛素耐药性和疲劳. 还注意到身体功能和肝脏炎症,这表明需要针对性的康复干预措施.
科学领域:
- 代谢功能的代谢功能
- 病毒感染的多器官影响
- 在COVID-19的后急性后果.
背景情况:
- 严重的COVID-19感染可能导致长期的健康并发症.
- 了解严重的COVID-19的多器官和代谢影响对于患者的康复至关重要.
研究的目的:
- 评估严重的COVID-19对患者住院后多器官和代谢功能的影响.
- 为了比较严重的COVID-19幸存者的新陈代谢和身体功能与健康的对照.
主要方法:
- 横截面研究比较了21名严重COVID-19幸存者与10名对照者.
- 通过口服葡萄糖耐受性测试 (OGTT) 和燃料氧化来评估代谢功能.
- 利用MRI,光谱,DXA,SPPB,EMG和力量测试来评估身体功能和器官健康.
主要成果:
- COVID-19幸存者在OGTT期间表现出明显更高的胰岛素反应,这表明胰岛素耐药性.
- 在患者中观察到较低的体力表现得分 (SPPB) 和每日步数.
- 在幸存者中发现肝脏体积增加和肝脏炎症标志物升高,以及感知到更大的疲劳.
结论:
- 在严重的COVID-19中幸存下来的个体表现出持续的胰岛素耐药性和减少的身体功能.
- 肝炎和疲劳增加是COVID-19后的重要后果.
- 建议在COVID-19恢复期间进行身体功能干预.
相关概念视频
01:30Pneumonia III: Complications and Assessment
198
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
198
01:21Acute Respiratory Failure-II
201
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
201
01:27Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
2.5K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
2.5K
01:30Acute Respiratory Failure-III
171
Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
171
01:21Acute Respiratory Failure-I
189
Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
189
01:29Acute Respiratory Failure-V
130
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Ensure that patients are monitored continuously for their response to therapy, including changes in...
130